Helpful Links & Resources
Amna Anees - author
Amna is a molecular biologist and has a deep interest in the field of health and medicine. She has worked in the field of proteomics and plants molecular biology. Being a biologist herself, she has developed an interest in the field of therapeutic studies of mesothelioma and related researches.
Amna Anees
5 mins read - August 28, 2024
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...
Amna Anees
2 mins read - August 22, 2024
A new biomaterial researchers have developed called GAG-DP is making a significant advancement when it comes to mesothelioma treatment. This has the potential to revolutionize...
Amna Anees
2 mins read - October 9, 2023
A groundbreaking study led by researchers at The University of Texas at Austin introduces a novel drug that restores the effectiveness of immune cells in combating cancer....
Amna Anees
2 mins read - January 17, 2023
Cutting-edge artificial intelligence (AI) technology has the potential to revolutionize care for patients presenting with acute chest pain, according to a groundbreaking study...
Amna Anees
2 mins read - May 25, 2022
A groundbreaking study published in the journal Radiology unveils the potential of artificial intelligence (AI) in revolutionizing cancer risk assessment for pulmonary nodules...
Amna Anees
2 mins read - May 3, 2022
A recent study published in the journal Radiology has revealed a concerning association between emphysema detected through CT scans and a heightened risk of developing lung cancer....
Amna Anees
2 mins read - March 30, 2022
Researchers at the University of Colorado Anschutz Medical Campus, alongside international collaborators, have made a significant discovery regarding the origin of mesothelioma, an...
Amna Anees
2 mins read - March 4, 2022
Bioengineers at Rice University have achieved a remarkable feat: eliminating advanced-stage ovarian and colorectal cancer in mice in as little as six days using a groundbreaking...
Amna Anees
2 mins read - February 14, 2022
A recent study, led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center, has revealed promising results in the treatment of...
Amna Anees
2 mins read - October 10, 2021
In the realm of mesothelioma treatment, immunotherapy emerges as a beacon of hope, with researchers striving to unravel its potential against this rare and aggressive disease....
Amna Anees
3 mins read - July 14, 2021
In a groundbreaking Phase II study, spearheaded by experts from The University of Texas MD Anderson Cancer Center, a formidable duo of drugs, atezolizumab, and bevacizumab, has...
Amna Anees
2 mins read - May 4, 2021
Protein staining tests are a useful tool in diagnosing sarcomatoid mesothelioma — the most aggressive mesothelioma cell type — but aren’t reliable enough on their own, according to...
Mesowatch's mission serves as an industry watchdog
and advocates for patients and families affected
by asbestos by providing reliable and up-to-date news
stories and information on asbestos and mesothelioma.
CONTACT US
Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship.